New Immuno-Oncology Targets and Resistance Mechanisms
Science in Seattle,
Immune checkpoint inhibition (ICI) has revolutionized the field of non-small cell lung cancer (NSCLC); currently, most patients…
Immune checkpoint inhibition (ICI) has revolutionized the field of non-small cell lung cancer (NSCLC); currently, most patients…
With Nadia Howlader, PhD, of the NCI's Division of Cancer Control
Ogni mese per i lettori di Oncoinfo una selezione dalla letteratura scientifica internazionale sul tema. The post Medicina di…
Deaths from the most common lung cancer, non-small cell lung cancer, declined sharply after 2013, faster than the drop in new…
According to a new study, mortality rates from the most common lung cancer, non-small cell lung cancer (NSCLC), have fallen…
Alex Nowbar reviews the latest research from the top medical…
Whether it’s exams, a COVID-19 test or a mid-treatment scan, waiting for results can be nerve-wracking. The anxiety. The…
SCLC incidence has also decreased, but survival post-Dx is not…
Kamala Harris on health.COVID data quality.African-American views on US health policy.Impact of treatment advances on lung…